Targeted Supplements Have Shown Potential Economic Savings
A new economic analysis indicates that specific supplements for adults 55 and over could yield significant long-term societal savings.
Updated on Sept. 29, 2026 in Heart Disease
Live Poll
Is now a good time to invest in preventative nutritional supplements for your heart health?
A new study projecting costs from 2025 through 2035 suggests that targeted use of certain supplements in adults 55 and older could generate as much as €8.30 in societal savings for every €1 spent. This analysis covers the 27 EU Member States and the UK, evaluating the potential impact of specific nutritional interventions on rising cardiovascular costs.
Why it matters
With cardiovascular disease costs in the region expected to climb from €307 billion in 2025 to €399 billion by 2035, identifying cost-effective preventive strategies is critical. This model highlights a potential pathway to offset the ballooning burden on healthcare and productivity systems.
Researchers used economic modeling to project the societal value of omega-3, phytosterols, and beta-glucan supplements in adults 55 and over. While the study estimates a high return on investment, these findings are based on theoretical models rather than direct, long-term clinical outcomes.
The players
European Commission
The executive branch of the European Union responsible for proposing legislation and implementing policy, including public health initiatives like the Safe Hearts Plan.
The details
The analysis evaluated the economic impact of daily supplementation, including 1,000 mg of omega-3 EPA and DHA, 1,500 mg of phytosterols, and 3,000 mg of beta-glucans. Researchers modeled potential reductions in cardiovascular events by subtracting the costs of these nutritional interventions from anticipated healthcare, social care, and productivity savings across the EU and the UK.
Timeline
2017: A previous Frost & Sullivan study was conducted on similar interventions.
December 2025: The European Commission launched the Safe Hearts Plan.
2025-2035: The period covered by the current economic analysis.
Health Landscape
This analysis provides a cost-efficiency framework for the goals established by the European Commission's Safe Hearts Plan. It sits within a broader shift toward quantifying the economic value of preventive nutritional interventions to mitigate the growing societal burden of cardiovascular disease.
If you are 55 or older, it is worth discussing with your doctor whether specific supplements like omega-3s or phytosterols are appropriate for your cardiovascular health profile. Relying on supplements as a preventive measure should always be part of a broader, clinically-supervised heart health plan.
The takeaway
This economic analysis underscores the potential for targeted nutrition to serve as a high-value tool in managing cardiovascular disease. Always discuss any planned supplement regimens with your physician to ensure they align with your existing care plan and do not interact with other treatments.
Further reading
For more information on current management strategies, visit our Heart Disease section.
Source note: This article includes information reported by NutraIngredients.
Live Poll
Is now a good time to invest in preventative nutritional supplements for your heart health?
